Cargando…

Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study

Background: High-density lipoprotein (HDL) plays an essential role in the immune system and shows effective antioxidative properties. We investigated correlations of lipid parameters with the sequential organ failure assessment (SOFA) score and the prognostic association with mortality in sepsis pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Reisinger, Alexander C., Schuller, Max, Holzer, Michael, Stadler, Julia T., Hackl, Gerald, Posch, Florian, Marsche, Gunther, Sourij, Harald, Ekart, Robert, Eller, Kathrin, Eller, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642222/
https://www.ncbi.nlm.nih.gov/pubmed/33195328
http://dx.doi.org/10.3389/fmed.2020.579677
_version_ 1783606049071169536
author Reisinger, Alexander C.
Schuller, Max
Holzer, Michael
Stadler, Julia T.
Hackl, Gerald
Posch, Florian
Marsche, Gunther
Sourij, Harald
Ekart, Robert
Eller, Kathrin
Eller, Philipp
author_facet Reisinger, Alexander C.
Schuller, Max
Holzer, Michael
Stadler, Julia T.
Hackl, Gerald
Posch, Florian
Marsche, Gunther
Sourij, Harald
Ekart, Robert
Eller, Kathrin
Eller, Philipp
author_sort Reisinger, Alexander C.
collection PubMed
description Background: High-density lipoprotein (HDL) plays an essential role in the immune system and shows effective antioxidative properties. We investigated correlations of lipid parameters with the sequential organ failure assessment (SOFA) score and the prognostic association with mortality in sepsis patients admitted to intensive care unit (ICU). Methods: We prospectively recruited consecutive adult patients with sepsis and septic shock, according to sepsis-3 criteria as well as non-sepsis ICU controls. Results: Fifty-three patients with sepsis (49% with septic shock) and 25 ICU controls without sepsis were enrolled. Dyslipidemia (HDL-C < 40 mg/l) was more common in sepsis compared to non-sepsis patients (85 vs. 52%, p = 0.002). Septic patients compared to controls had reduced HDL-C (14 vs. 39 mg/l, p < 0.0001), lower arylesterase activity of the antioxidative paraoxonase of HDL (AEA) (67 vs. 111 mM/min/ml serum, p < 0.0001), and a non-significant trend toward reduced cholesterol efflux capacity (9 vs. 10%, p = 0.091). We observed a strong association between higher AEA and lower risk of 28-day [per 10 mM/min/ml serum increase in AEA: odds ratio (OR) = 0.76; 95% CI, 0.61–0.94; p = 0.01) and ICU mortality (per 10 mM/min/ml serum increase in AEA: OR = 0.71, 95% CI, 0.56–0.90, p = 0.004) in the sepsis cohort in univariable logistic regression analysis. AEA was confirmed as an independent predictor of 28-day and ICU mortality in multivariable analyses. AEA discriminated well-regarding 28-day/ICU mortality in area under the receiver operating characteristic curve (AUROC) analyses. In survival analysis, 28-day mortality estimates were 40 and 69% with AEA ≥/< the 25th percentile of AEA's distribution, respectively (log-rank p = 0.0035). Conclusions: Both compositional and functional HDL parameters are profoundly altered during sepsis. In particular, the functionality parameter AEA shows promising prognostic potential in sepsis patients.
format Online
Article
Text
id pubmed-7642222
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76422222020-11-13 Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study Reisinger, Alexander C. Schuller, Max Holzer, Michael Stadler, Julia T. Hackl, Gerald Posch, Florian Marsche, Gunther Sourij, Harald Ekart, Robert Eller, Kathrin Eller, Philipp Front Med (Lausanne) Medicine Background: High-density lipoprotein (HDL) plays an essential role in the immune system and shows effective antioxidative properties. We investigated correlations of lipid parameters with the sequential organ failure assessment (SOFA) score and the prognostic association with mortality in sepsis patients admitted to intensive care unit (ICU). Methods: We prospectively recruited consecutive adult patients with sepsis and septic shock, according to sepsis-3 criteria as well as non-sepsis ICU controls. Results: Fifty-three patients with sepsis (49% with septic shock) and 25 ICU controls without sepsis were enrolled. Dyslipidemia (HDL-C < 40 mg/l) was more common in sepsis compared to non-sepsis patients (85 vs. 52%, p = 0.002). Septic patients compared to controls had reduced HDL-C (14 vs. 39 mg/l, p < 0.0001), lower arylesterase activity of the antioxidative paraoxonase of HDL (AEA) (67 vs. 111 mM/min/ml serum, p < 0.0001), and a non-significant trend toward reduced cholesterol efflux capacity (9 vs. 10%, p = 0.091). We observed a strong association between higher AEA and lower risk of 28-day [per 10 mM/min/ml serum increase in AEA: odds ratio (OR) = 0.76; 95% CI, 0.61–0.94; p = 0.01) and ICU mortality (per 10 mM/min/ml serum increase in AEA: OR = 0.71, 95% CI, 0.56–0.90, p = 0.004) in the sepsis cohort in univariable logistic regression analysis. AEA was confirmed as an independent predictor of 28-day and ICU mortality in multivariable analyses. AEA discriminated well-regarding 28-day/ICU mortality in area under the receiver operating characteristic curve (AUROC) analyses. In survival analysis, 28-day mortality estimates were 40 and 69% with AEA ≥/< the 25th percentile of AEA's distribution, respectively (log-rank p = 0.0035). Conclusions: Both compositional and functional HDL parameters are profoundly altered during sepsis. In particular, the functionality parameter AEA shows promising prognostic potential in sepsis patients. Frontiers Media S.A. 2020-10-22 /pmc/articles/PMC7642222/ /pubmed/33195328 http://dx.doi.org/10.3389/fmed.2020.579677 Text en Copyright © 2020 Reisinger, Schuller, Holzer, Stadler, Hackl, Posch, Marsche, Sourij, Ekart, Eller and Eller. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Reisinger, Alexander C.
Schuller, Max
Holzer, Michael
Stadler, Julia T.
Hackl, Gerald
Posch, Florian
Marsche, Gunther
Sourij, Harald
Ekart, Robert
Eller, Kathrin
Eller, Philipp
Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
title Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
title_full Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
title_fullStr Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
title_full_unstemmed Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
title_short Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
title_sort arylesterase activity of hdl associated paraoxonase as a potential prognostic marker in patients with sepsis and septic shock—a prospective pilot study
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642222/
https://www.ncbi.nlm.nih.gov/pubmed/33195328
http://dx.doi.org/10.3389/fmed.2020.579677
work_keys_str_mv AT reisingeralexanderc arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy
AT schullermax arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy
AT holzermichael arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy
AT stadlerjuliat arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy
AT hacklgerald arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy
AT poschflorian arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy
AT marschegunther arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy
AT sourijharald arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy
AT ekartrobert arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy
AT ellerkathrin arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy
AT ellerphilipp arylesteraseactivityofhdlassociatedparaoxonaseasapotentialprognosticmarkerinpatientswithsepsisandsepticshockaprospectivepilotstudy